PHB blocks endoplasmic reticulum stress and apoptosis induced by MPTP/MPP+ in PD models

Xiaohong Wang1, Dongyi Ding2, Lei Wu3

  • 1School of Medicine, Yangzhou University, Yangzhou 225001, China; Jiangsu Key Laboratory of Experimental & Translational Non-coding RNA ResearchNoncoding RNA Center, Yangzhou University, YangZhou 225001, China; Jiangsu Co-innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses, Yangzhou, 225009, China.

Insights

Prohibitin (PHB) protein protects against Parkinson's disease (PD) by preserving mitochondrial function and reducing endoplasmic reticulum (ER) stress. Genetic manipulation of PHB shows potential for PD treatment.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Genetics

Background:

  • Mitochondrial dysfunction and ER stress are implicated in Parkinson's disease (PD) pathogenesis.
  • Prohibitin (PHB), a mitochondrial protein, may play a role in PD development.

Purpose of the Study:

  • To investigate the functional role of PHB in mitochondrial biogenesis and ER stress in PD models.
  • To evaluate the therapeutic potential of PHB manipulation in PD.

Main Methods:

  • Utilized in vitro (MPP+-treated SH-SY5Y cells) and in vivo (MPTP-induced mouse model) PD models.
  • Overexpressed PHB in neuronal cells and PD mice.
  • Assessed cell death, apoptosis, ER stress markers, reactive oxygen species, and motor function.

Main Results:

  • PHB overexpression protected against MPP+-induced cell death and apoptosis in SH-SY5Y cells.
  • PHB inhibited ER stress markers and neurodegeneration in MPTP-treated mice.
  • PHB reduced reactive oxygen species, ER stress, and autophagic stress in PD models.

Conclusions:

  • PHB protects dopaminergic neurons by maintaining mitochondrial function and alleviating ER stress.
  • Genetic manipulation of PHB presents a potential therapeutic strategy for Parkinson's disease.

Related Concept Videos

Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
752
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.2K
EPS and iPS Cells in Disease Research01:21

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
3.1K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
7.4K